A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor

Diabetes, Obesity and Metabolism

Volumn 5, Issue 6, 2003, Pages 388-396

  Novak, Suzanne ^a   Stapleton, L M ^a   Litaker, J R ^a   Lawson, K A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Confirmatory factor analysis; Insulin resistance; Metabolic syndrome

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FACTORIAL ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RELIABILITY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SWEDEN;

EID: 0345328765     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2003.00289.x     Document Type: Article

References (42)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
2. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome (syndrome X). Diabetologia 1992; 34: 416-422.
3. Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ. Do different dimensions of the metabolic syndrome change together over time? Diabetes Care 2001; 24: 1758-1763.
4. Laaksonen DE, Lakka H, Niskanen LK, Kaplan GA, Jukka TS, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-1077.
5. World Health Organization. Definitions Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, World Health Org, 1999 (available from: http://www.staff.ncl.ac.uk/philip.home/who_dmc.htm).
6. Meigs JB. Epidemiology of the metabolic syndrome. Am J Manage Care 2002; 8 (Suppl.): S281-S291.
7. Lakka H, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
8. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
9. American Association of Clinical Endocrinologists. Findings and recommendations from the American College Of Endocrinology Conference on the insulin resistance syndrome (available from: http://www.aace.com/pub/irsc/findings,php).
10. Gabir MM, Hanson RL, Dabelea D et al. The 1997 American Diabetes Association and the 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2002; 23: 1108-1112.
11. Zimmet P. Diabetes and endocrinology ask the expert: impaired fasting glycemia and impaired glucose tolerance. Medscape: Diabetes Endocrinology 2003 (available from: http://www.medscape.com/veiwarticle/450364).
12. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000; 23: 171-175.
13. De Fronzo RA, Tobin OD, Andreas R. Glucose clamp technique: a method of quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
14. Balkau B, Charles MA. The European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO consultation. Diabet Med 1999; 16: 443-443.
15. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1992; 137: 959-965.
16. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes 2002; 51: 3120-3127.
17. Young TK, Chateau D, Zhang M. Factor analysis of ethnic variation in the metabolic (insulin resistance) syndrome in three Canadian populations. Am J Human Biol 2002; 14: 649-658.
18. Stevens J. Applied Multivariate Statistics for the Social Sciences, 3rd edn. Mahwah, NJ: Erlbaum, 1996.
19. Kline RB. Principles and Practice of Structural Equation Modeling. New York: Guilford Press, 1998.
20. Crocker L, Algina J. Introduction to Classical and Modern Test Theory. Holt: Rinehart and Winston, 1986.
21. Hair JF, Anderson RE, Tatham RL, Black WC. Multivariate Data Analysis, 4th edn. New York: Macmillan Publishing Company, 1995.
22. Rosmond R, Björntorp P. The hypothalamic-pituitary adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 2000; 247: 188-197.
23. Rosmond R, Dallman MF, Björntorp P. Stress related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83: 1853-1859.
24. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling: a Multidisciplinary Journal 1999; 6: 1-55.
25. Meigs JB, D'Agostino RB, Wilson PWF, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome: the Framingham offspring study. Diabetes 1997; 46: 1594-1600.
26. Gray RS, Fabsitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ. Risk factor clustering in the insulin resistance syndrome: the strong heart study. Am J Epidemiol 1998; 148: 869-878.
27. Edwards L, Burchfiel CM, Sharp DS et al. Factors of the insulin-resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 1998; 147: 441-447.
28. Reaven G. Metabolic Syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002; 106: 286-288.
29. Ferrannini E, Natali A, Bell P, Cavallo-Perrin P, Lalic N, Mingrone G. On behalf of the European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest 1997; 100: 1166-1173.
30. Bogardus C, Lilloja S, Mott D, Reaven G, Kashiwagi A, Foley J. Relationship between obesity and maximal insulin stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 1984; 73: 800-805.
31. Jeppsen J, Hein HO, Suadicani P, Gyntelberg F. Low triglycerides high density lipoprotein cholesterol and risk of ischemic heart disease. Arch Intern Med 2001; 161: 361-366.
32. Gaziano JM, Hennekens CH, O'Donnell CJ et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infraction. Circulation 1997; 96: 2520-2525.
33. Kuczmarkski RJ, Carrol MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1989-94). Obes Res 1997; 5: 542-548.
34. Temelkova-Kurktschiev T, Koehler C, Schaper F et al. Originals: relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia 1998; 41: 706-712.
35. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990; 13: 153-169.
36. Yoshino G, Hirano T, Kazumi T. Dyslipidemia in diabetes mellitus. Diabetes Res Clin Pract 1996; 33: 1-14.
37. Weyer C, Hanson RL, Tataranni A, Bogardus C, Pratley RE. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 2000; 49: 2094.
38. Meigs JB, Nathan DN, D'Agostino RB, Wilson PWF. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care 2002; 25: 1845-1850.
39. Meigs JB, Mittleman MA, Nathan DM et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham offspring study. JAMA 2000; 283: 211-228.
40. Hanson RL, Pratley RE, Bogardus C et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies, Am J Epidemiol 2000; 151: 190-198.
41. Anderson RL, Hamman RF, Savage PJ et al. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance tests: the insulin resistance atherosclerosis study. Am J Epidemiol 1995; 142: 724-732.
42. Shen B, Todaro JF, Niaura R et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 2003; 157: 701-711.